Monthly reportRWANDAFDA
Rwanda Food and Drugs Authority — March 2020
What this register recorded from RWANDAFDA in March 2020, what other African authorities published in the same month that bears on it, and what we could not read in RWANDAFDA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Rwanda Food and Drugs Authority.
What RWANDAFDA published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-RW-2020-35442000 | 04 Mar 2020 | RW | BEU Hand Sanitizers Holly Trust Ltd/Kamonyi District | none published | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2020-77105885 | 15 Mar 2020 | RW | Hand Sanitizers Manufactured by Oxalis Ltd Oxalis Ltd | none published | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2020-44653909 | 19 Mar 2020 | RW | Amoxicilline 250 mg capsules CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG CO.LTD ) / HEBEI /CHINA | 767190205 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-RW-2020-48266756 | 19 Mar 2020 | RW | Cloxacillin BP 250 mg capsules, REYOUNG PHARMACEUTICAL.CO.LTD/CHINA | 183132400 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-RW-2020-51833554 | 19 Mar 2020 | RW | Entamizole DS ( Diloxanide furoate/ metronidazole 500/400mg) ABBOTT LAB/PAKISTAN | 94965XV · 95532XV | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2020-57341098 | 19 Mar 2020 | RW | Amoxycillin BP 250 mg capsules (AMOXIMED)/1000 capsules, CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG CO.LTD ) / HEBEI /CHINA | 767190207 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-RW-2020-75842395 | 19 Mar 2020 | RW | Amoxycillin BP 250 mg capsules (AMOXIMED)/1000 capsules, CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG CO.LTD ) / HEBEI /CHINA | 767190216 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-RW-2020-79465256 | 19 Mar 2020 | RW | Cloxacillin 250 mg capsules, REYOUNG PHARMACEUTICAL.CO.LTD/CHINA | 1831132401 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-RW-2020-88340031 | 19 Mar 2020 | RW | Amoxycillin BP 250 mg capsules (AMOXIMED)/1000 capsules, CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG CO.LTD ) / HEBEI /CHINA | 767190208 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-RW-2020-94004442 | 19 Mar 2020 | RW | Cloxacillin BP 250 mg capsules, REYOUNG PHARMACEUTICAL.CO.LTD/CHINA | 183132399 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-RW-2020-94949920 | 19 Mar 2020 | RW | Amoxycillin BP 250 mg capsules, CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG CO.LTD ) / HEBEI /CHINA | 767190217 | Recall | Class III | Tier 1 · Regulator-published |
What other authorities published
What we could not read in RWANDAFDA’s notices
- 159 record(s) held from RWANDAFDA in total
- 2 carry no publication date we could read
- 22 name neither a batch nor a stated reason
- 1 name no manufacturer
- 2 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 0 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about Rwanda Food and Drugs Authority can be corrected by Rwanda Food and Drugs Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.